These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8600291)

  • 1. Chlorpyrifos oxon interacts with the mammalian multidrug resistance protein, P-glycoprotein.
    Lanning CL; Fine RL; Sachs CW; Rao US; Corcoran JJ; Abou-Donia MB
    J Toxicol Environ Health; 1996 Mar; 47(4):395-407. PubMed ID: 8600291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
    Huff RA; Corcoran JJ; Anderson JK; Abou-Donia MB
    J Pharmacol Exp Ther; 1994 Apr; 269(1):329-35. PubMed ID: 7513360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-dependent binding of chlorpyrifos oxon to acetylcholinesterase.
    Sultatos LG
    Toxicol Sci; 2007 Nov; 100(1):128-35. PubMed ID: 17702992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase.
    Huff RA; Abou-Donia MB
    Neurotoxicology; 1995; 16(2):281-90. PubMed ID: 7566687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of organophosphorus anticholinesterases on muscarinic receptor-mediated inhibition of acetylcholine release in rat striatum.
    Liu J; Chakraborti T; Pope C
    Toxicol Appl Pharmacol; 2002 Jan; 178(2):102-8. PubMed ID: 11814330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S
    Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed characterization of cysteine-less P-glycoprotein reveals subtle pharmacological differences in function from wild-type protein.
    Taylor AM; Storm J; Soceneantu L; Linton KJ; Gabriel M; Martin C; Woodhouse J; Blott E; Higgins CF; Callaghan R
    Br J Pharmacol; 2001 Dec; 134(8):1609-18. PubMed ID: 11739236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of P-Glycoprotein Is Associated With Chlorpyrifos Resistance in the German Cockroach (Blattodea: Blattellidae).
    Hou W; Jiang C; Zhou X; Qian K; Wang L; Shen Y; Zhao Y
    J Econ Entomol; 2016 Dec; 109(6):2500-2505. PubMed ID: 27634281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport.
    Zhang S; Morris ME
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1258-67. PubMed ID: 12604704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells.
    Wang Y; Georges E
    Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of the organophosphorus insecticides chlorpyrifos and fenitrothion by perfused rat liver.
    Sultatos LG
    Toxicology; 1991; 68(1):1-9. PubMed ID: 1714638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of two rat hepatic proteins with A-esterase activity toward chlorpyrifos-oxon and paraoxon.
    Pond AL; Chambers HW; Coyne CP; Chambers JE
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1404-11. PubMed ID: 9732404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of organic chemicals with P-glycoprotein in the adrenal gland, kidney, and a multidrug-resistant KB cell.
    Ichikawa M; Yoshimura A; Sumizawa T; Shudo N; Kuwazuru Y; Furukawa T; Akiyama S
    J Biol Chem; 1991 Jan; 266(2):903-8. PubMed ID: 1670776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
    Mutch E; Daly AK; Williams FM
    Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of trans-permethrin hydrolysis in human liver fractions by chloropyrifos oxon and carbaryl.
    Choi J; Hodgson E; Rose RL
    Drug Metabol Drug Interact; 2004; 20(4):233-46. PubMed ID: 15663293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactive toxicity of chlorpyrifos and parathion in neonatal rats: role of esterases in exposure sequence-dependent toxicity.
    Kacham R; Karanth S; Baireddy P; Liu J; Pope C
    Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):142-9. PubMed ID: 16260018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentration-dependent interactions of the organophosphates chlorpyrifos oxon and methyl paraoxon with human recombinant acetylcholinesterase.
    Kaushik R; Rosenfeld CA; Sultatos LG
    Toxicol Appl Pharmacol; 2007 Jun; 221(2):243-50. PubMed ID: 17467020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alpha-interferon on P-glycoprotein expression and function and on verapamil modulation of doxorubicin resistance.
    Kang Y; Perry RR
    Cancer Res; 1994 Jun; 54(11):2952-8. PubMed ID: 7910518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.